Insmed Inc (INSM)
48.06
+26.06
(+118.45%)
USD |
NASDAQ |
May 28, 16:00
47.55
-0.51
(-1.06%)
After-Hours: 07:21
Insmed Cash and Short Term Investments (Quarterly): 595.73M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 595.73M |
December 31, 2023 | 780.45M |
September 30, 2023 | 785.95M |
June 30, 2023 | 917.77M |
March 31, 2023 | 998.68M |
December 31, 2022 | 1.148B |
September 30, 2022 | 513.30M |
June 30, 2022 | 554.87M |
March 31, 2022 | 635.12M |
December 31, 2021 | 716.78M |
September 30, 2021 | 846.56M |
June 30, 2021 | 928.33M |
March 31, 2021 | 409.75M |
December 31, 2020 | 532.76M |
September 30, 2020 | 588.75M |
June 30, 2020 | 641.91M |
March 31, 2020 | 428.94M |
December 31, 2019 | 487.43M |
September 30, 2019 | 535.63M |
June 30, 2019 | 601.26M |
March 31, 2019 | 420.23M |
December 31, 2018 | 495.07M |
September 30, 2018 | 567.57M |
June 30, 2018 | 634.33M |
March 31, 2018 | 686.58M |
Date | Value |
---|---|
December 31, 2017 | 381.16M |
September 30, 2017 | 430.68M |
June 30, 2017 | 91.06M |
March 31, 2017 | 125.84M |
December 31, 2016 | 162.59M |
September 30, 2016 | 200.52M |
June 30, 2016 | 223.11M |
March 31, 2016 | 252.87M |
December 31, 2015 | 282.88M |
September 30, 2015 | 310.97M |
June 30, 2015 | 335.03M |
March 31, 2015 | 134.55M |
December 31, 2014 | 159.23M |
September 30, 2014 | 167.31M |
June 30, 2014 | 82.70M |
March 31, 2014 | 101.25M |
December 31, 2013 | 113.89M |
September 30, 2013 | 128.02M |
June 30, 2013 | 76.78M |
March 31, 2013 | 81.61M |
December 31, 2012 | 92.94M |
September 30, 2012 | 89.75M |
June 30, 2012 | 73.14M |
March 31, 2012 | 70.78M |
December 31, 2011 | 76.27M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
409.75M
Minimum
Mar 2021
1.148B
Maximum
Dec 2022
682.41M
Average
618.19M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
Cytokinetics Inc | 618.96M |
Amicus Therapeutics Inc | 239.60M |
Altimmune Inc | 182.02M |
United Therapeutics Corp | 2.708B |
InfuSystems Holdings Inc | 0.822M |